págs. 1-1
págs. 2-14
Combating biopiracy in Australia: Will a disclosure requirement in the Patents Act 1990be more effective than the current regulations?
Verity Dawkins
págs. 15-31
WTO “Paragraph 6” system for affordable access to medicines: Relief or regulatory ritualism?
Muhammad Z. Abbas, Shamreeza Riaz
págs. 32-51
Impact of patent policy changes on R&D expenditure by industries in India
Ruchi Sharma, Audhesh K. Paswan, Sunil K. Ambrammal, Madan Dhanora
págs. 52-69
Broadening the conversation on the TRIPS agreement: Access to medicines includes addressing access to medical devices
Hembadoon Iyortyer Oguanobi
págs. 70-87
Japan's emerging role in the global pharmaceutical intellectual property regime: A tale of two trade agreements
Belinda Townsend, Deborah Gleeson, Ruth Lopert
págs. 88-103